Selda Samakoglu
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Hemoglobinopathies and Related Disorders
- Virus-based gene therapy research
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- CRISPR and Genetic Engineering 4
- Genetics 7
- Virus-based gene therapy research 6
- Hemoglobinopathies and Related Disorders 5
- Co-authors
- Isabelle Rivière (5 shared papers)Stephen M. Ansell (2 shared papers)Leszek Lisowski (4 shared papers)John M. Timmerman (2 shared papers)Peter Johnson (2 shared papers)Scott J. Rodig (2 shared papers)Anne Sumbul (2 shared papers)Philippe Armand (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Best Practice & Research Clinical Haematology (2 papers)Blood (2 papers)Molecular Therapy (1 paper)Neoplasia (1 paper)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Selda Samakoglu
19 papers receiving 628 citations
Peers
Comparison fields: 5 of 54
- Genetics 165
- Pathology and Forensic Medicine 258
- Oncology 353
- Immunology 165
- Hematology 62
Countries citing papers authored by Selda Samakoglu
This map shows the geographic impact of Selda Samakoglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Selda Samakoglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Selda Samakoglu more than expected).
Fields of papers citing papers by Selda Samakoglu
This network shows the impact of papers produced by Selda Samakoglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Selda Samakoglu. The network helps show where Selda Samakoglu may publish in the future.
Co-authors
The 25 scholars most cited alongside Selda Samakoglu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 249 | |
| 2 | 2005 | 91 | |
| 3 | 2020 | 70 | |
| 4 | 2019 | 66 | |
| 5 | 2005 | 27 | |
| 6 | 2001 | 21 | |
| 7 | Preclinical rationale for combining an EGFR antibody with cisplatin/gemcitabine for the treatment of NSCLC. | 2012 | 20 |
| 8 | 1999 | 16 | |
| 9 | 2002 | 16 | |
| 10 | 2004 | 15 | |
| 11 | 2011 | 14 | |
| 12 | 2004 | 12 | |
| 13 | 2020 | 6 | |
| 14 | 2008 | 3 | |
| 15 | Estimating preclinical efficacy targets utilizing cetuximab efficacy in KRAS mutant and wild-type colorectal cancer models. | 2011 | 2 |
| 16 | 2021 | 2 | |
| 17 | 2022 | 2 | |
| 18 | 2018 | 2 | |
| 19 | 2010 | 1 | |
| 20 | 2025 | 0 |
About Selda Samakoglu
Selda Samakoglu is a scholar working on Molecular Biology, Genetics, Oncology, Genetics and Pathology and Forensic Medicine, having authored 20 papers that have together received 635 indexed citations. Recurring topics across this work include Virus-based gene therapy research (6 papers), Hemoglobinopathies and Related Disorders (5 papers), CRISPR and Genetic Engineering (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Colorectal Cancer Treatments and Studies (2 papers), Cancer Treatment and Pharmacology (2 papers), Cancer Research and Treatments (2 papers) and Iron Metabolism and Disorders (2 papers). The work is most often cited by research in Genetics (165 citations), Pathology and Forensic Medicine (258 citations), Oncology (353 citations), Immunology (165 citations) and Hematology (62 citations). Selda Samakoglu has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Isabelle Rivière, Stephen M. Ansell, Leszek Lisowski, John M. Timmerman, Peter Johnson, Scott J. Rodig, Anne Sumbul, Philippe Armand, Michel Sadelain and Margaretha G.M. Roemer. Their work appears in journals such as Journal of Clinical Oncology, Best Practice & Research Clinical Haematology, Blood, Molecular Therapy and Neoplasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.